Slides
Talk at CDISC 2020 Europe Interchange Virtual Conference
The European Health Data & Evidence Network (EHDEN) project, funded via the Innovative Medicines Initiative (IMI), is the largest of its kind in Europe working in the domain of RWD/RWE. At its core is the standardisation of RWD via use of the Observational Medical Outcomes Partnership (OMOP) common data model (CDM), standardised analytics and a sustainable research community for the coming decades. Potentially, between EHDEN and OHDSI there are several use cases developed on the boundaries between clinical trials and observational data, and we look forward discussing these with the CDISC community.
Talk at BioData World Congress 2019
At the Bio Data World conference in Basel in December 2019, Kees van Bochove, Founder of The Hyve gave a talk on re-use of pharma R&D data, and what strategies could be used to realize operationalization of FAIR data at scale.
Keynote at Proventa International’s Bioinformatics East Coast Strategy Meeting 2019 and Talk at Pharmaceutical IT & Data Congress 2019
- Fairspace: a new cloud service to enable collaborative science
- Implementation of FAIR in practice: which of the 15 principles to start with and what’s the RoI?
- Common Data Models: OMOP/OHDSI, i2b2/tranSMART, CDISC, FHIR, etc: how do they relate, and which one to choose
Large scale observational clinical research with OHDSI
Talk at i2b2 tranSMART Tübingen Symposium 2019
With 200 researchers from 25 countries and half a billion unique patients, OHDSI carries out federated studies at sufficient scale to answer questions about diagnosis and treatment. At the heart of the OHDSI platform is the OMOP Common Data Model, currently at v6, around which a toolset is built for carrying out reusable, repeatable and reproducible observational clinical research on a large scale.
Talk at i2b2 tranSMART Tübingen Symposium 2019
Glowing Bear is a cohort selection user interface for the TranSMART clinical data warehouse. In recent years, features for several use cases have been added: time series data, standard ontologies, family relations, sample-level lab data. Meanwhile, the structure of the platform has been transformed to be more modular and maintainable. We give an overview of the added features and the changes to the data model and architecture.
Talk at i2b2 tranSMART Tübingen Symposium 2019
Deployment of tranSMART and all its dependencies used to be a complex task, mainly because of many dependencies, different versions and configuration options. With the new structure of the platform, dockerization of all its components and a main compose scripts it is not only faster to deploy everything, but also easier to manage the configuration, ensure security and monitor the components.
Talk at i2b2 tranSMART Tübingen Symposium 2019
An overview of data loading tools to tranSMART 17.X for Jupyter Notebook and automated ETL pipelines
Tackling the Clinical Data Challenges When Analyzing a Million Genomes
Talk at BioIT World 2019
Population genetics and genomics is an emerging topic for the application of machine learning methods in healthcare and biomedical sciences. Currently, several large genomics initiatives […] are all in the process of making both clinical and genomics data available from large numbers of patients to benefit biomedical research. However, a key challenge in these initiatives is the standardization of the clinical and outcomes data in such a way that machine learning methods can be effectively trained to discover useful medical and scientific insights.
Applying the OMOP data model & OHDSI software to national European health data registries: the IMI EMIF project
Talk at SCOPE Summit 2017 – Real World Data track
A large open source initiative for standardisation and epidemiological analysis for real world data is OHDSI: Observational Health Data Sciences and Informatics. OHDSI leverages the OMOP common data model for observational data, and provides data analysis tools for a broad range of use cases. This talk will explain OMOP and OHDSI with case study IMI EMIF, in which health data from over 50 million patients from 13 national and regional European registries is brought together.
